The global metabolomics biomarker market is anticipated to grow at a considerable CAGR of around 12% during the forecast. Metabolomics is an emerging field of ‘‘omics’’ research that focuses on the high-throughput characterization of small molecule metabolites in biological matrices. The approaches of metabolomics are applied in the biological systems, including humans, plants, and microorganisms.
Browse the full report description Global Metabolomics Biomarker Market by Application (Toxicological Studies, Drug Testing, and Diagnosis), by Technology (Chromatography, Nuclear Magnetic Resonance, Mass Spectrometry, and Others), By End-User (Hospitals and Diagnostic Labs & Research Centers) - Global Industry Share, Growth, Competitive Analysis and Forecast Period 2020-2026 at https://www.omrglobal.com/industry-reports/metabolomics-biomarker-market
The advancement of metabolomics technologies provides improved diagnosis, more appropriate therapeutic targets, and allows a more accurate prognosis of disease development. The recent development of instrumental systems such as mass spectrometry, ultra-performance liquid chromatography, high-resolution NMR spectroscopy, and more advanced bioinformatics and analytical technologies has facilitated more wide-ranging exposure of the metabolome. Therefore, innovative development in informatics and analytical technologies is driving the market growth.
Market coverage
o By Application
o By Technology
o By End-User
o North America
o Europe
o Asia-Pacific
o Rest of the world
Key Questions Addressed By the Report
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
Global Metabolomics Biomarker Market Report Segment
By Application
By Technology
By End-User
Global Metabolomics Biomarker Market Report Segment by Region
North America
Europe
Asia-Pacific
Rest of the World
To learn more about this report request a free sample copy
@ https://www.omrglobal.com/request-sample/metabolomics-biomarker-market